• Home
  • E-submission
  • Sitemap
  • Contact us
  • Search
  • Advanced Search
Intest Res Search

CLOSE

‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

April 20, 2023


Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions
Harris A. Ahmad, James E. East, Remo Panaccione, et al.
Intest Res. 2023;21(3):283-294.

Inflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis and is characterized by uncontrolled, relapsing, and remitting course of inflammation in the gastrointestinal tract. Artificial intelligence represents a new era...

Review

May 31, 2023


Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer
Chan Hyung Lee, Seong-Joon Koh, Zaher A Radi, et al.
Intest Res. 2023;21(3):295-305.

Inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, is a lifelong disease that manifests with chronic intestinal inflammation, sequential fibrosis, and an increased risk of colitis-associated colon cancer...

Review

April 20, 2023


Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?
Emiko Mizoguchi, Takayuki Sadanaga, Toshiyuki Okada, et al.
Intest Res. 2023;21(3):306-317.

Caffeine (1,3,7-trimethylxanthine, also abbreviated to CAF) is a natural chemical with stimulant effects and is commonly included in many drinks and foods, including coffee, tea, cola, energy drinks, cocoa, chocolates,...

Original Article

February 10, 2023


Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
Yasuhiro Aoki, Hiroki Kiyohara, Yohei Mikami, et al.
Intest Res. 2023;21(3):318-327.

Background/Aims: Thromboprophylaxis is recommended for hospitalized patients with inflammatory bowel disease (IBD) in Western countries, although it is selectively administered to high-risk patients in East Asia. A central venous catheter...

Original Article

July 27, 2023


Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Han Hee Lee, Jae Jun Park, Bo-In Lee, et al.
Intest Res. 2023;21(3):328-338.

Background/Aims: Inflammatory bowel disease (IBD) is no longer a rare disease in Asia, thus it needs to prepare recommendations relevant to Asian patients. This study aimed to identify disparities in...

Original Article

July 27, 2023


Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Eun Mi Song, Soo-Young Na, Sung Noh Hong, et al.
Intest Res. 2023;21(3):339-352.

Background/Aims: As the characteristics of inflammatory bowel disease (IBD) differ between Asians and Westerners, it is necessary to determine adequate therapeutic strategy for Asian IBD patients. We evaluated the current...

Original Article

July 27, 2023


Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, et al.
Intest Res. 2023;21(3):353-362.

Background/Aims: Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with...

Original Article

June 16, 2023


Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Su Bum Park, Kyeong Ok Kim, Hong Sub Lee, et al.
Intest Res. 2023;21(3):363-374.

Background/Aims: Long-term immunosuppressive therapies used to treat inflammatory bowel disease (IBD) are associated with an increased risk of infections, many of which can be prevented by vaccination. We assessed physicians’...

Original Article

October 18, 2022


Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
Arshdeep Singh, Yogesh Kumar Gupta, Ashvin Singh Dhaliwal, et al.
Intest Res. 2023;21(3):375-384.

Background/Aims: The inflammatory bowel disease (IBD)-disk is a validated, visual, 10-item, self-administered questionnaire used to evaluate IBD-related disability. The present study aimed to evaluate IBD-disk in assessment of IBD daily...

Original Article

March 17, 2023


Submucosal fat accumulation in Crohn’s disease: evaluation with sonography
Tomás Ripollés, María Jesús Martínez-Pérez, José María Paredes, et al.
Intest Res. 2023;21(3):385-391.

Background/Aims: The study objective is to investigate the ultrasound features that allow suspecting the presence of submucosal fat deposition, called the fat halo sign (FHS), in the intestinal wall of...

Original Article

December 2, 2022


Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, et al.
Intest Res. 2023;21(3):392-405.

Background/Aims: The data on the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with inflammatory bowel disease (IBD) are conflicting. The present systematic review...
Current Issue
Volume 21(3); Jul 2023
Does CVC placement increase the risk of venous thromboembolism in hospitalized IBD patients without pharmacological prophylactic antithrombotic therapy?

Epub August 3, 2023
Concomitant ankylosing spondylitis with inflammatory bowel disease: Clinical significance in terms of clinical outcomes

Epub May 9, 2023
Are the incidence rates of hospitalized infections, herpes zoster, and malignancies different depending on treatment drugs in patients with ulcerative colitis?

Epub February 3, 2023
Can educational training decrease excessive and inappropriate steroid use in patients with inflammatory bowel disease?

Epub November 3, 2022
Is bile acid metabolism related to dysbiosis in patients with Crohn’s disease?

Epub August 1, 2022
Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?

Epub April 29, 2022
Are thiopurines safe and effective for patients with NUDT15 heterozygosity?

Epub February 7, 2022
How often is immunoglobulin A nephropathy associated in patients with inflammatory bowel diseases?

Epub November 2, 2021
Could the geographic area influence the demographic profile of IBD patients in India?

Epub April 29, 2021
Could melatonin ameliorate the intestinal inflammation by modulating intestinal microbial composition?

Epub August 10, 2020
What are the risk factors for impaired ovarian reserve in young women of reproductive age with Crohn's disease?

Epub April 22, 2020
Who should continue the budesonide 2-mg foam treatment for up to week 6 in patients with mild-to-moderate distal ulcerative colitis?

Epub February 18, 2020
How common is family history of inflammatory bowel disease and how does it relate to the prognosis in patients with inflammatory bowel disease in Asia?

Epub October 13, 2019
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study

Epub August 2, 2019
Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children’s immunity

Epub April 23, 2019
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis

Epub February 7, 2019
Fecal immunochemical test and fecal calprotectin in ulcerative colitis

Epub November 1, 2018
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease

Epub August 9, 2018
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study

Epub May 8, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment

Epub February 5, 2018
Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease

Epub November 2, 2017
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease

Epub September 1, 2017
  • Journal Impact Factor 4.9
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD
ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next